Daniel Rubino
Neuromusculoskeletal Medicine, Sports Medicine · Devon, PANPI 1669481578
Payments from drug & device makers
Across 269 payments — averaging $16.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$1K
- Pfizer$374
- Lilly USA, LLC$188
- Amgen$164
- Idorsia Pharmaceuticals US Inc$150
- plus $1K from 25 others
What the payments were for
- Food & beverage$4,313100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 67 | $1,101 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 75 | $1,015 |
| Pfizer | 20 | $374 |
| Lilly USA, LLC | 11 | $188 |
| Amgen(2 entities) | 10 | $164 |
| Idorsia Pharmaceuticals US Inc | 7 | $150 |
| Collegium Pharmaceutical, Inc. | 9 | $140 |
| Biodelivery Sciences International, Inc. | 8 | $121 |
| Scilex Pharmaceuticals Inc. | 5 | $108 |
| Lundbeck LLC | 5 | $96 |
| Biohaven Pharmaceutical Holding Company Ltd. | 6 | $94 |
| Biohaven Pharmaceuticals, Inc. | 5 | $75 |
| Almatica Pharma LLC | 4 | $73 |
| MDD US Operations, LLC | 3 | $70 |
| Redhill Biopharma Inc. | 4 | $69 |
| IBSA Pharma Inc. | 3 | $54 |
| Eisai Inc. | 3 | $47 |
| Daiichi Sankyo Inc. | 3 | $46 |
| Azurity Pharmaceuticals, Inc. | 2 | $44 |
| Assertio Therapeutics, Inc. | 3 | $42 |
| Teva Pharmaceuticals USA, Inc. | 3 | $34 |
| Arbor Pharmaceuticals, Inc. | 2 | $32 |
| AstraZeneca | 2 | $30 |
| Orexo US, Inc. | 2 | $26 |
| Valinor Pharma, LLC | 1 | $24 |
| Upsher-smith Laboratories LLC | 1 | $22 |
| Novartis | 1 | $20 |
| Clarus Therapeutics Inc. | 1 | $16 |
| Bausch Health US, LLC | 1 | $15 |
| Shionogi Inc | 1 | $12 |
| Sentynl Therapeutics, Inc. | 1 | $12 |
How this compares
Too few neuromusculoskeletal medicine, sports medicine providers in Pennsylvaniato place this figure against a meaningful peer group, so we don't.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Xtampza ErOxycodone Myristate | 108 | $88,807 |
| OxycontinOxycodone Hcl | 88 | $75,286 |
| RelistorMethylnaltrexone Bromide | 23 | $51,012 |
| Oxycodone Hcl | 481 | $13,682 |
| MovantikNaloxegol Oxalate | 30 | $12,061 |
| Diclofenac Epolamine | 13 | $8,117 |
| Spiriva HandihalerTiotropium Bromide | 12 | $6,401 |
| Morphine Sulfate ErMorphine Sulfate | 125 | $4,012 |
| Lidocaine | 19 | $3,093 |
| Morphine Sulfate | 61 | $2,675 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 13 | $2,451 |
| Pregabalin | 119 | $2,450 |
| Doxepin Hcl | 12 | $2,362 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 74 | $2,301 |
| Fentanyl | 12 | $1,354 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Xtampza Er | $140 | $88,807108 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCRelistor | $1,015 | $51,01223 claims |
| Redhill Biopharma Inc.Movantik | $69 | $12,06130 claims |
| Almatica Pharma LLCSertraline Hcl | $73 | $27013 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few neuromusculoskeletal medicine, sports medicine providers in Pennsylvaniaon file to place this against a meaningful peer group, so we don't.
Other neuromusculoskeletal medicine, sports medicine in Devon
- David CooperWilkes-Barre$2K
- John PerriPittsburgh$18
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.